INSM logo

Insmed Incorporated (INSM) EBIT

annual EBIT:

-$829.81M-$159.05M(-23.71%)
December 31, 2024

Summary

  • As of today (May 22, 2025), INSM annual earnings before interest & taxes is -$829.81 million, with the most recent change of -$159.05 million (-23.71%) on December 31, 2024.
  • During the last 3 years, INSM annual EBIT has fallen by -$431.98 million (-108.58%).
  • INSM annual EBIT is now -793.77% below its all-time high of $119.61 million, reached on December 31, 2009.

Performance

INSM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

quarterly EBIT:

-$235.92M-$21.44M(-10.00%)
March 31, 2025

Summary

  • As of today (May 22, 2025), INSM quarterly earnings before interest & taxes is -$235.92 million, with the most recent change of -$21.44 million (-10.00%) on March 31, 2025.
  • Over the past year, INSM quarterly EBIT has dropped by -$99.37 million (-72.77%).
  • INSM quarterly EBIT is now -295.25% below its all-time high of $120.83 million, reached on March 31, 2009.

Performance

INSM quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

TTM EBIT:

-$929.17M-$99.37M(-11.97%)
March 31, 2025

Summary

  • As of today (May 22, 2025), INSM TTM earnings before interest & taxes is -$929.17 million, with the most recent change of -$99.37 million (-11.97%) on March 31, 2025.
  • Over the past year, INSM TTM EBIT has dropped by -$262.79 million (-39.44%).
  • INSM TTM EBIT is now -876.85% below its all-time high of $119.61 million, reached on December 31, 2009.

Performance

INSM TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

INSM EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-23.7%-72.8%-39.4%
3 y3 years-108.6%-157.1%-128.7%
5 y5 years-265.1%-298.1%-324.4%

INSM EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-108.6%at low-157.1%+15.6%-137.1%at low
5 y5-year-265.1%at low-334.4%+15.6%-335.7%at low
alltimeall time-793.8%at low-295.3%+15.6%-876.9%at low

INSM EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$235.92M(+10.0%)
-$929.17M(+12.0%)
Dec 2024
-$829.81M(+23.7%)
-$214.48M(+7.7%)
-$829.81M(+6.3%)
Sep 2024
-
-$199.18M(-28.8%)
-$780.57M(+8.3%)
Jun 2024
-
-$279.59M(+104.7%)
-$720.67M(+8.1%)
Mar 2024
-
-$136.56M(-17.4%)
-$666.38M(-0.7%)
Dec 2023
-$670.76M(+46.6%)
-$165.24M(+18.6%)
-$670.76M(+3.1%)
Sep 2023
-
-$139.28M(-38.2%)
-$650.59M(+1.7%)
Jun 2023
-
-$225.31M(+59.9%)
-$639.56M(+26.2%)
Mar 2023
-
-$140.93M(-2.9%)
-$506.86M(+10.7%)
Dec 2022
-$457.70M(+15.0%)
-$145.08M(+13.1%)
-$457.70M(+10.0%)
Sep 2022
-
-$128.24M(+38.5%)
-$416.18M(+6.2%)
Jun 2022
-
-$92.61M(+0.9%)
-$391.98M(-3.5%)
Mar 2022
-
-$91.77M(-11.4%)
-$406.21M(+1.9%)
Dec 2021
-$397.83M(+50.4%)
-$103.56M(-0.5%)
-$398.64M(+2.3%)
Sep 2021
-
-$104.05M(-2.6%)
-$389.52M(+13.9%)
Jun 2021
-
-$106.84M(+26.9%)
-$341.98M(+18.1%)
Mar 2021
-
-$84.19M(-10.9%)
-$289.45M(+9.4%)
Dec 2020
-$264.52M(+16.4%)
-$94.44M(+67.1%)
-$264.52M(+22.6%)
Sep 2020
-
-$56.51M(+4.1%)
-$215.75M(+1.2%)
Jun 2020
-
-$54.31M(-8.4%)
-$213.28M(-2.6%)
Mar 2020
-
-$59.27M(+29.8%)
-$218.96M(-3.7%)
Dec 2019
-$227.25M(-24.3%)
-$45.67M(-15.5%)
-$227.25M(-14.8%)
Sep 2019
-
-$54.04M(-9.9%)
-$266.77M(-9.3%)
Jun 2019
-
-$59.99M(-11.2%)
-$294.18M(-3.4%)
Mar 2019
-
-$67.56M(-20.7%)
-$304.38M(+1.5%)
Dec 2018
-$300.00M(+59.8%)
-$85.19M(+4.6%)
-$300.00M(+7.4%)
Sep 2018
-
-$81.44M(+16.0%)
-$279.28M(+15.6%)
Jun 2018
-
-$70.19M(+11.1%)
-$241.69M(+12.6%)
Mar 2018
-
-$63.18M(-2.0%)
-$214.64M(+14.4%)
Dec 2017
-$187.77M(+8.7%)
-$64.46M(+47.0%)
-$187.57M(-1.3%)
Sep 2017
-
-$43.85M(+1.6%)
-$190.00M(+3.8%)
Jun 2017
-
-$43.15M(+19.5%)
-$183.12M(+4.1%)
Mar 2017
-
-$36.11M(-46.0%)
-$175.91M(+1.9%)
Dec 2016
-$172.68M(+47.3%)
-$66.89M(+81.0%)
-$172.68M(+24.9%)
Sep 2016
-
-$36.97M(+2.9%)
-$138.28M(+5.1%)
Jun 2016
-
-$35.94M(+9.3%)
-$131.55M(+6.5%)
Mar 2016
-
-$32.88M(+1.2%)
-$123.50M(+5.3%)
Dec 2015
-$117.27M(+34.5%)
-$32.49M(+7.5%)
-$117.27M(+8.7%)
Sep 2015
-
-$30.24M(+8.4%)
-$107.83M(+6.8%)
Jun 2015
-
-$27.89M(+4.7%)
-$100.99M(+5.5%)
Mar 2015
-
-$26.65M(+15.6%)
-$95.73M(+9.8%)
Dec 2014
-$87.17M(+58.8%)
-$23.06M(-1.4%)
-$87.17M(+9.4%)
Sep 2014
-
-$23.40M(+3.4%)
-$79.71M(+9.0%)
Jun 2014
-
-$22.63M(+25.2%)
-$73.12M(+24.5%)
Mar 2014
-
-$18.08M(+15.9%)
-$58.71M(+7.0%)
Dec 2013
-$54.88M(+35.1%)
-$15.60M(-7.1%)
-$54.88M(+1.3%)
Sep 2013
-
-$16.80M(+104.4%)
-$54.19M(+16.4%)
Jun 2013
-
-$8.22M(-42.3%)
-$46.55M(-3.1%)
Mar 2013
-
-$14.26M(-4.4%)
-$48.03M(+18.3%)
Dec 2012
-$40.61M
-$14.92M(+62.8%)
-$40.61M(+19.9%)
Sep 2012
-
-$9.16M(-5.5%)
-$33.86M(-42.9%)
Jun 2012
-
-$9.69M(+41.7%)
-$59.29M(-0.5%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$6.84M(-16.2%)
-$59.61M(-0.1%)
Dec 2011
-$59.65M(+854.9%)
-$8.16M(-76.4%)
-$59.65M(+4.2%)
Sep 2011
-
-$34.59M(+245.4%)
-$57.26M(+149.8%)
Jun 2011
-
-$10.01M(+45.4%)
-$22.92M(+72.6%)
Mar 2011
-
-$6.89M(+19.5%)
-$13.28M(+112.6%)
Dec 2010
-$6.25M(-105.2%)
-$5.76M(+2178.7%)
-$6.25M(+1313.3%)
Sep 2010
-
-$253.00K(-32.5%)
-$442.00K(+63.1%)
Jun 2010
-
-$375.00K(-356.8%)
-$271.00K(-74.8%)
Mar 2010
-
$146.00K(+265.0%)
-$1.08M(-100.9%)
Dec 2009
$119.61M(-930.0%)
$40.00K(-148.8%)
$119.61M(+3.3%)
Sep 2009
-
-$82.00K(-93.1%)
$115.83M(+1.6%)
Jun 2009
-
-$1.18M(-101.0%)
$114.03M(+2.9%)
Mar 2009
-
$120.83M(-3332.5%)
$110.77M(-845.6%)
Dec 2008
-$14.41M(-29.5%)
-$3.74M(+98.2%)
-$14.86M(+2.7%)
Sep 2008
-
-$1.89M(-57.5%)
-$14.46M(-13.4%)
Jun 2008
-
-$4.43M(-7.6%)
-$16.70M(+12.6%)
Mar 2008
-
-$4.80M(+43.5%)
-$14.83M(-27.4%)
Dec 2007
-$20.44M(-62.4%)
-$3.34M(-18.9%)
-$20.44M(-46.9%)
Sep 2007
-
-$4.12M(+60.5%)
-$38.50M(-18.3%)
Jun 2007
-
-$2.57M(-75.3%)
-$47.10M(-12.5%)
Mar 2007
-
-$10.40M(-51.4%)
-$53.85M(-1.0%)
Dec 2006
-$54.37M(+98.2%)
-$21.40M(+68.2%)
-$54.37M(+35.8%)
Sep 2006
-
-$12.72M(+36.5%)
-$40.03M(+13.7%)
Jun 2006
-
-$9.32M(-14.6%)
-$35.20M(+7.2%)
Mar 2006
-
-$10.92M(+54.6%)
-$32.83M(+19.7%)
Dec 2005
-$27.43M(+0.0%)
-$7.06M(-10.5%)
-$27.43M(+4.5%)
Sep 2005
-
-$7.90M(+13.6%)
-$26.25M(+1.0%)
Jun 2005
-
-$6.95M(+25.9%)
-$26.00M(-7.5%)
Mar 2005
-
-$5.52M(-6.1%)
-$28.11M(+2.5%)
Dec 2004
-$27.43M(+159.1%)
-$5.88M(-23.1%)
-$27.43M(+14.1%)
Sep 2004
-
-$7.65M(-15.6%)
-$24.05M(+27.5%)
Jun 2004
-
-$9.06M(+87.4%)
-$18.87M(+43.8%)
Mar 2004
-
-$4.83M(+93.1%)
-$13.12M(+23.9%)
Dec 2003
-$10.59M(-69.3%)
-$2.50M(+1.5%)
-$10.59M(-60.4%)
Sep 2003
-
-$2.47M(-25.5%)
-$26.71M(+0.7%)
Jun 2003
-
-$3.31M(+44.0%)
-$26.52M(-13.0%)
Mar 2003
-
-$2.30M(-87.6%)
-$30.48M(-11.6%)
Dec 2002
-$34.49M(-14.2%)
-$18.62M(+717.2%)
-$34.49M(+32.1%)
Sep 2002
-
-$2.28M(-68.7%)
-$26.11M(-20.4%)
Jun 2002
-
-$7.28M(+15.4%)
-$32.80M(-6.7%)
Mar 2002
-
-$6.31M(-38.4%)
-$35.15M(-12.5%)
Dec 2001
-$40.19M(+29.2%)
-$10.24M(+14.1%)
-$40.19M(-448.9%)
Sep 2001
-
-$8.97M(-6.8%)
$11.52M(-22.9%)
Jun 2001
-
-$9.63M(-15.1%)
$14.95M(-148.2%)
Mar 2001
-
-$11.35M(-127.4%)
-$31.02M(-0.2%)
Dec 2000
-$31.10M(+282.5%)
$41.47M(-847.8%)
-$31.10M(-57.1%)
Sep 2000
-
-$5.54M(-90.0%)
-$72.56M(+8.3%)
Jun 2000
-
-$55.60M(+386.9%)
-$67.02M(+411.8%)
Mar 2000
-
-$11.42M(+581.3%)
-$13.10M(+302.2%)
Dec 1999
-$8.13M
-
-
Jun 1999
-
-$1.68M(+6.1%)
-$3.26M(+106.1%)
Mar 1999
-
-$1.58M
-$1.58M

FAQ

  • What is Insmed Incorporated annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Insmed Incorporated?
  • What is Insmed Incorporated annual EBIT year-on-year change?
  • What is Insmed Incorporated quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Insmed Incorporated?
  • What is Insmed Incorporated quarterly EBIT year-on-year change?
  • What is Insmed Incorporated TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Insmed Incorporated?
  • What is Insmed Incorporated TTM EBIT year-on-year change?

What is Insmed Incorporated annual earnings before interest & taxes?

The current annual EBIT of INSM is -$829.81M

What is the all time high annual EBIT for Insmed Incorporated?

Insmed Incorporated all-time high annual earnings before interest & taxes is $119.61M

What is Insmed Incorporated annual EBIT year-on-year change?

Over the past year, INSM annual earnings before interest & taxes has changed by -$159.05M (-23.71%)

What is Insmed Incorporated quarterly earnings before interest & taxes?

The current quarterly EBIT of INSM is -$235.92M

What is the all time high quarterly EBIT for Insmed Incorporated?

Insmed Incorporated all-time high quarterly earnings before interest & taxes is $120.83M

What is Insmed Incorporated quarterly EBIT year-on-year change?

Over the past year, INSM quarterly earnings before interest & taxes has changed by -$99.37M (-72.77%)

What is Insmed Incorporated TTM earnings before interest & taxes?

The current TTM EBIT of INSM is -$929.17M

What is the all time high TTM EBIT for Insmed Incorporated?

Insmed Incorporated all-time high TTM earnings before interest & taxes is $119.61M

What is Insmed Incorporated TTM EBIT year-on-year change?

Over the past year, INSM TTM earnings before interest & taxes has changed by -$262.79M (-39.44%)
On this page